Visualizaciones | |
---|---|
Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial | 337 |
mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | septiembre 2024 | octubre 2024 | noviembre 2024 | |
---|---|---|---|---|---|---|---|
Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial | 5 | 1 | 3 | 6 | 5 | 4 | 2 |
Visualizaciones | |
---|---|
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf.jpg | 428 |
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf | 286 |
C1.2. Rossetti_Diabetes Technol Ther. 2012_ibolus for mealtime insulin dosing in T1DM.pdf.txt | 1 |
Visualizaciones | |
---|---|
Estados Unidos | 198 |
Francia | 30 |
China | 28 |
España | 27 |
Alemania | 17 |
Reino Unido | 4 |
Rusia | 4 |
Finlandia | 3 |
India | 3 |
Japón | 3 |
Visualizaciones | |
---|---|
Ashburn | 34 |
Redmond | 23 |
Louisville | 19 |
Valencia | 16 |
Grenoble | 13 |
Mountain View | 13 |
Villeurbanne | 8 |
Beijing | 7 |
Alameda | 5 |
Costa Mesa | 5 |